Are you a journalist? Please sign up here for our press releases
Subscribe to our monthly newsletter:
Weizmann Institute researchers identify a biomarker that may one day enable a subgroup of lung cancer patients to benefit from relapse-free...
Three drugs together block growth from without and within
Portrazza is approved to by the US FDA to treat lung cancer